No abstract available.
Sodium

No abstract available.
Sodium

No abstract available.
Sodium Tetradecyl Sulfate* ; Sodium*

No abstract available.
Perilymph* ; Sodium Salicylate* ; Sodium*

Due to a failure in communication, the original rather than revised manuscript.
Ganoderma* ; Sodium Chloride* ; Sodium*

No abstract available.
Chlorhexidine ; Sodium ; Sodium Hypochlorite

No abstract available.
Sodium* ; Stomach*

No abstract available.
Hypertension* ; Sodium*

The study involved 47 patients with hypernatremia who have clinical symptoms and the blood sodium level more than 150 mmol/l between January 1998 and June 2001. Results: hypernatremia is observed at the Intensive Care Unit with rate of 2.7%. It is more likely to occur in 1-year children. It can be required during hospitalization and developed in the patients who are using manitol, bicarbonate sodium and diuretics. The central nervous symptoms include seizures, increase in muscular tone, unconsciousness, coma, fever and dehydration. 31.9% of patients high and very high blood sodium level. The treatment has low effect on patients who have blood sodium level more than 170 mmol/l. The average time to normalize sodium level is 1.8 days with amount of solution during 4 to 6 hours to correct Na+ level is 19.8 ml/kg/h. During subsequent hours, amount of solution is different depending on body fluid disorder of patient.
Hypernatremia ; Sodium

This was a prospective study comparing the cost implications between two carbon dioxide (CO2) absorbers, soda lime (Intersurgical) and AMSORB® PLUS. The study was conducted over two 4-week periods in two dedicated operating theatres using Datex Ohmeda Aestiva/5 anaesthetic machines. AMSORB® PLUS was used during the first four weeks and soda lime (Intersurgical) the following four weeks. General anaesthesia was administered as routinely done but fresh gas flow (FGF) during the maintenance phase was limited to a maximum flow of 2 L/min. The CO2 absorber was only changed when there was evidence of exhaustion. Total duration of anaesthesia, sevoflurane (bottles) and CO2 absorber (kg) consumption, and amount of waste product (kg) was calculated at the end of each study period. The total cost of delivering general anaesthesia was lower in the AMSORB® PLUS group, RM82.40 (USD19.89)/hour versus the soda lime group, RM91.50 (USD 22.09)/hour (p=0.17), which translates to a 10% reduction in cost per hour. Reduction in sevoflurane consumption in the AMSORB® PLUS compared to the soda lime group was also not statistically significant (p=0.22). The only significant finding was the reduction in CO2 absorber consumption in the AMSORB® PLUS group as compared to soda lime group (p=0.001). In conclusion, AMSORB® PLUS consumption was significantly reduced compared to that of soda lime. However, the use of AMSORB® PLUS did not significantly reduce sevoflurane consumption nor the total cost of delivering general anaesthesia. Given the superior safety profile, AMSORB® PLUS may be a suitable, cost-effective alternative to soda lime in the daily practice of anaesthesia.
Sodium Hydroxide